| Report period | 2018 | 2019 | 2020 | 2021 | 2022 | Q3 23 | 
|---|---|---|---|---|---|---|
| End date of the reporting period | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | 
| Capitalization, $ | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | 
| Capitalization, $ | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | 
| Enterprise Value | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | 
| Book Value | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | 
| Shareholders Book Value | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | 
| Current liabilities | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | 
| Noncurrent liabilities | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | 
| Total liabilities | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | 
| Debt | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | 
| Cash and cash equivalents | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | 
| Net debt | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | 
| Assets | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | 
| Total ordinary shares | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | 
| Ordinary share price | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | ![]()  | 
 sec.gov
 sec.gov
 sec.gov
 sec.gov| Company name | InMode | 
|---|---|
| Tags | #medtech | 
| Sector | Health Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment | 
| Business address | TAVOR BUILDING, SHA?AR YOKNEAM POB 533 YOKNEAM L3 2069200 972-4-9097470 | 
| Mailing address | TAVOR BUILDING, SHA?AR YOKNEAM POB 533 YOKNEAM L3 2069200 | 
| Website | www.inmodemd.com | 
| Information disclosure | www.sec.gov |